|
Market Closed -
Hong Kong S.E.
16:08:27 30/09/2026 HKT
|
5-day change | 1st Jan Change | ||
| 1.020 HKD | -7.27% |
|
-3.77% | -77.53% |
Company Valuation: Cutia Therapeutics
Data adjusted to current consolidation scope
| Fiscal Period: December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 3,030 | 2,120 | 1,482 | 325.4 | - | - |
| Change | - | -30.05% | -30.06% | -78.05% | - | - |
| Enterprise Value (EV) | 2,471 | 2,055 | 1,469 | 325.4 | 325.4 | 325.4 |
| Change | - | -16.83% | -28.53% | -77.85% | 0% | 0% |
| P/E | -1.04x | -4.72x | -3.96x | 29.1x | 6.23x | - |
| PBR | 2.25x | 2.17x | 1.52x | 0.49x | 0.46x | - |
| PEG | -0x | 0.1x | 0.1x | -0x | 0x | - |
| Capitalization / Revenue | 22x | 7.58x | 4.41x | 0.55x | 0.34x | 0.24x |
| EV / Revenue | 0x | 0x | 0x | 0.55x | 0.34x | 0.24x |
| EV / EBITDA | -0x | -0x | -0x | 12.5x | 4.52x | - |
| EV / EBIT | -0x | -0x | -0x | 32.5x | 5.92x | 3.35x |
| EV / FCF | -0x | -0x | -0x | -11.2x | -10.2x | -7.75x |
| FCF Yield | -14.4% | -22.1% | -20.4% | -8.91% | -9.83% | -12.9% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -9.6 | -1.41 | -1.03 | 0.03 | 0.14 | - |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 137.6 | 279.6 | 336.2 | 588 | 961 | 1,336 |
| EBITDA 1 | -498 | -419.9 | -257.9 | 26 | 72 | - |
| EBIT 1 | -538.9 | -461.1 | -300.1 | 10 | 55 | 97 |
| Net income 1 | -1,964 | -433.8 | -340.2 | 10 | 50 | - |
| Net Debt | -559.6 | -64.73 | -13.8 | - | - | - |
| Reference price 2 | 9.9667 | 6.6531 | 4.0798 | 0.8719 | 0.8719 | 0.8719 |
| Nbr of stocks (in thousands) | 304,024 | 318,588 | 363,368 | 373,171 | - | - |
| Announcement Date | 27/3/24 | 24/3/25 | 24/3/26 | - | - | - |
1CNY in Million2CNY
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 29.06x | - | - | - | 48.51M | |
| 32.9x | 11.93x | 24.23x | 0.6% | 1,031B | |
| 29.45x | 6.54x | 18.31x | 2.02% | 638B | |
| 33.1x | 7.75x | 16.02x | 2.65% | 462B | |
| 105.72x | 5.91x | 25.05x | 2.35% | 359B | |
| 19x | 4.63x | 11.48x | 2.87% | 335B | |
| 20.37x | 5.28x | 13.08x | 3.03% | 273B | |
| 20.79x | 4.31x | 12.28x | 2.05% | 253B | |
| 26.62x | 6.92x | 12.32x | 2.39% | 228B | |
| -45.08x | 6.57x | 25.65x | 2.21% | 185B | |
| Average | 27.19x | 6.65x | 17.60x | 2.24% | 376.39B | |
| Weighted average by Cap. | 32.10x | 7.72x | 18.90x | 1.92% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 2487 Stock
- Valuation Cutia Therapeutics
Select your edition
All financial news and data tailored to specific country editions
